Diabetes device trial to improve blood sugar and weight
Part of Hormones & metabolism clinical trials.
This study tests the RESET System to help people with type 2 diabetes lower their average blood sugar (HbA1c) despite current medication. It may also affect weight and safety outcomes by changing how food moves through the gut.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 22 and 65 years old
- Have type 2 diabetes, with HbA1c between 7.5% and 10%
- Have a body mass index (BMI) between 30 and 50
- Be able to follow all study visits, tests, and daily reporting
- Have tried “dual therapy” diabetes medicines for at least 3 months, but HbA1c still hasn’t gone below 7.5%
- Women who could become pregnant must have a negative pregnancy test and use effective birth control during the whole study (and after removal if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an endoscopic (camera-guided) stomach tightening/suturing procedure plus standard diabetes care can improve health in people with type 2 diabetes and mild-to-moderate obesity. It compares this procedure to standard care alone to see which approach works better and is safe.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This study tests an experimental medication called ARO-INHBE in adults with obesity, including those who also have type 2 diabetes. The goal is to see if it helps with weight loss and is safe.
This trial tests a new device, called the Trans-Duodenal Barrier, for people with type 2 diabetes and obesity. The goal is to see if the device can help with weight loss and blood sugar control.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.